INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery

Part of paid clinical trials in Tampa, Florida.

Sponsor
Abiomed Inc.
Study ID
NCT06965504
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Cardiogenic Shock
  • Heart Failure
  • Reduced Ejection Fraction Heart Failure

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • Impella 5.5 SmartAssist — DEVICE
    The intervention is Impella 5.5 with SmartAssist® support combined with protocolized guideline directed medical therapy (GDMT) and HF-CS best practices.

Study Details

The study will evaluate the impact of a combined device-drug strategy with Impella 5.5 with best practices and optimized GDMT on heart recovery outcomes in patients with decompensated heart failure and cardiogenic shock.

Key Dates

Start date
Apr 1, 2026
Status verified
Apr 2026
Primary completion
Dec 1, 2028
Completion
Jun 1, 2029

Study Design

Enrollment
250 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Other: Single arm study
    This is a single arm study.

Primary Outcome Measure

Composite of all-cause death, HF hospitalization, and heart replacement (heart transplantation or durable LVAD implantation) [ Time Frame: Timeframe: 180-days post-enrollment ]

Central Contacts

Locations (7)

FacilityCityStateZIPSite coordinators
Tampa General HospitalTampaFlorida33606
Courtney Nicholas, BS RN, CCRP, CVRN-BC
[email protected]
813-844-4914
Debbie Rinde-Hoffman, MD, FACC, FACP, FHFSA (PRINCIPAL_INVESTIGATOR)
Abbott NorthwesternMinneapolisMinnesota555407
Juilanne Feola
[email protected]
612-863-6066
Kasia Hryniewicz, MD (PRINCIPAL_INVESTIGATOR)
Rutgers-Robert Wood Johnson Medical SchoolNew BrunswickNew Jersey08901
Manisha Bajpai, MD
[email protected]
732-258-3649
Maya Guglin, MD, PhD (PRINCIPAL_INVESTIGATOR)
Atrium HealthCharlotteNorth Carolina28204
Haley Bonilla
[email protected]
704-468-3193
Priyesh Patel, M.D. (PRINCIPAL_INVESTIGATOR)
Duke UniversityDurhamNorth Carolina27710
Elyse Wilson
[email protected]
(919) 681-8879
Adam DeVore, MD, MHS, FHFSA, FAHA, FACC (PRINCIPAL_INVESTIGATOR)
University of Pennsylvania Health SystemPhiladelphiaPennsylvania19104
Alyson Brown
[email protected]
215-662-2128
Joyce Wald, DO, FACC (PRINCIPAL_INVESTIGATOR)
Centennial Medical CenterNashvilleTennessee32703
Kristen Kuhn
[email protected]
615.982.0640
Thomas McRae, MD, FACC (PRINCIPAL_INVESTIGATOR)
Zachary J II'Giovine, MD, FACC (PRINCIPAL_INVESTIGATOR)

Find similar trials in Tampa, FL

By condition
Heart failure
By specialty
CardiologyHeart disease
By research site
Tampa General Hospital· Tampa, FLAbbott Northwestern· Minneapolis, MNRutgers-Robert Wood Johnson Medical School· New Brunswick, NJAtrium Health· Charlotte, NCDuke University· Durham, NCUniversity of Pennsylvania Health System· Philadelphia, PA

Related Studies